Results 51 to 60 of about 202 (68)

Recent Updates on the Diagnosis and Management of Age-Related Macular Degeneration. [PDF]

Mayo Clin Proc Innov Qual Outcomes
Boopathiraj N, Wagner IV, Dorairaj SK, Miller DD, Stewart MW.   +4 more
europepmc   +1 more source

Nucleic acid therapeutics: Past, present, and future. [PDF]

Mol Ther Nucleic Acids
Naeem S, Zhang J, Zhang Y, Wang Y.
europepmc   +1 more source

Aptamers as new promising entities for therapeutics: our experience from the neurological diseases. [PDF]

Neural Regen Res
Hernández-Jiménez M, de Castro F.
europepmc   +1 more source

Geographic Atrophy in Patients with Age-Related Macular Degeneration Is Associated with Rare Variants in Complement Factor H and Complement Factor I. [PDF]

Ophthalmol Sci
de Breuk A, de Jong S, Bakker B, Kersten E, Luttikhuizen DT, Fauser S, Klaver CCW, den Hollander AI, Hoyng CB, Lechanteur YTE.   +9 more
europepmc   +1 more source

The gut-eye axis in age-related macular degeneration: from microbial dysbiosis to targeted intervention strategies. [PDF]

Exp Biol Med (Maywood)
Wang N, Luo L, Yang X.
europepmc   +1 more source

Biofeedback Fixation Training in the Rehabilitation of Patients with Geographic Atrophy. [PDF]

Life (Basel)
Vörös K, Kovács I, Kézdy G, Élő Á, Szilágyi Z, Barboni M, Récsán Z, Nagy ZZ, Ecsedy M.   +8 more
europepmc   +1 more source

Systems biology can provide guidance to synthetic biology in the pursuit of new drug targets. [PDF]

Front Pharmacol
Voit EO.
europepmc   +1 more source

Small RNA or oligonucleotide drugs and challenges in evaluating drug-drug interactions. [PDF]

Front Pharmacol
Cronin JM, Yu AM.
europepmc   +1 more source

The Complement System as a Therapeutic Target in Retinal Disease. [PDF]

Medicina (Kaunas)
Ong J, Zarnegar A, Selvam A, Driban M, Chhablani J.   +4 more
europepmc   +1 more source

Dry and neovascular "wet" age-related macular degeneration: Upcoming therapies. [PDF]

Indian J Ophthalmol
Yan A, Hasan N, Chhablani J.
europepmc   +1 more source